Feasibility of Video Gaming Technology for Arm Recovery Early Post-stroke
Launched by JOHNS HOPKINS UNIVERSITY · Nov 13, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of video game technology to help people recover their arm function after having a stroke. Researchers believe that playing these engaging video games, which work alongside robotic tools, can make rehabilitation more enjoyable and effective. The goal is to see if using this technology early in the recovery process is safe and beneficial for patients who have experienced a stroke.
To participate in the trial, individuals must be receiving treatment in specific rehabilitation units and have weakness in one arm. However, there are some important criteria that could exclude someone from joining, such as being unable to sit up for a few minutes or having serious medical conditions that could interfere with participation. If eligible, participants can expect to play video games designed to help improve their arm movement while receiving support from therapists. Overall, this trial aims to explore innovative ways to enhance recovery for stroke patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Admitted to Meyer 7 inpatient rehabilitation unit (CIIRP) or Zayed 12 West (12W) Brain Rescue Unit (BRU)
- • 2. Unilateral upper extremity weakness (as defined as change in functional use of extremity from baseline or difference in MMT score from unaffected side to affected side)
- Exclusion Criteria:
- • 1. Unable to sit upright for at least 3 minutes
- • 2. Unable to follow 1 step commands
- • 3. Vision impairment that impedes seeing the television screen
- • 4. Medical instability as defined by the care provider
- • 5. Orthopedic range of motion precautions including, but not limited to: no active range of motion or weight bearing of the target extremity
- • 6. Heart condition that limits participation in exercise
- • 7. Active seizures or epilepsy
- • 8. Inability to communicate pain status
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Mona Bahouth, MD, PhD
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported